{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:31:55Z","timestamp":1791973915111,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41375-024-02504-3","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T02:53:42Z","timestamp":1736909622000},"page":"675-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic impact of expression of CD2, CD25, and\/or CD30 in\/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-1724","authenticated-orcid":false,"given":"Axel","family":"R\u00fcfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1323-3116","authenticated-orcid":false,"given":"Henning","family":"Nilius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Niedoszytko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne N. G.","family":"Oude Elberink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Shoumariyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Gulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Sabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Angelova-Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Baffoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Belloni Fortina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Breynaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-8947","authenticated-orcid":false,"given":"Nikolas","family":"von Bubnoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horia","family":"Bumbea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"van Daele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-6282","authenticated-orcid":false,"given":"Michael","family":"Doubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingunn","family":"Dybedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Elena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Fokoloros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"G\u00f3rska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Heizmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2270-0804","authenticated-orcid":false,"given":"Madlen","family":"Jentzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8847-2704","authenticated-orcid":false,"given":"Saskia","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0767-1504","authenticated-orcid":false,"given":"Johannes","family":"L\u00fcbke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-3112","authenticated-orcid":false,"given":"Jens","family":"Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja Daniela","family":"Schug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarita","family":"Scium\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Sztormowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"V\u00e1rkonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-1710","authenticated-orcid":false,"given":"Friederike","family":"Wortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif Selim","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8253-6156","authenticated-orcid":false,"given":"Jason","family":"Gotlib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-6507","authenticated-orcid":false,"given":"Andreas","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-5095","authenticated-orcid":false,"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"2504_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603\u201325.","journal-title":"Leuk Res."},{"key":"2504_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L, F\u00f6dinger M, Hartmann K, Brockow K, et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 2007;37:435\u201353.","journal-title":"Eur J Clin Invest."},{"key":"2504_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMra1409760","volume":"373","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC, Valent P, Akin C. Mast cells, mastocytosis, and related disorders. N Engl J Med. 2015;373:163\u201372.","journal-title":"N Engl J Med"},{"key":"2504_CR4","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","volume":"5","author":"P Valent","year":"2021","unstructured":"Valent P, Akin C, Hartmann K, Alvarez-Twose I, Brockow K, Hermine O, et al. Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. HemaSphere. 2021;5:e646.","journal-title":"HemaSphere"},{"key":"2504_CR5","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolympoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36:1703\u201319.","journal-title":"Leukemia"},{"key":"2504_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.iac.2023.04.011","volume":"432","author":"P Valent","year":"2023","unstructured":"Valent P, Sotlar K, Horny HP, Arock M, Akin C. World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives. Immunol Allergy Clin North Am. 2023;432:627\u201349.","journal-title":"Immunol Allergy Clin North Am"},{"key":"2504_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka H-M, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200\u201328.","journal-title":"Blood"},{"key":"2504_CR8","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jaci.2022.04.012","volume":"149","author":"M Tsai","year":"2022","unstructured":"Tsai M, Valent P, Galli SJ. KIT as a master regulator of the mast cell lineage. J Allergy Clin Immunol. 2022;149:1845\u201354.","journal-title":"J Allergy Clin Immunol"},{"key":"2504_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.iac.2023.04.008","volume":"43","author":"Y Chantran","year":"2023","unstructured":"Chantran Y, Valent P, Arock M. KIT mutations and other genetic defects in mastocytosis: implications for disease pathology and targeted therapies. Immunol Allergy Clin North Am. 2023;43:651\u201364.","journal-title":"Immunol Allergy Clin North Am"},{"key":"2504_CR10","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1016\/j.jaip.2023.08.008","volume":"11","author":"P Valent","year":"2023","unstructured":"Valent P, Hoermann G, Bonadonna P, Hartmann K, Sperr WR, Broesby-Olsen S, et al. The normal range of baseline tryptase should be 1 to 15 ng\/ml and covers healthy individuals with H\u03b1T. J Allergy Clin Immunol Pr. 2023;11:3010\u201320.","journal-title":"J Allergy Clin Immunol Pr"},{"key":"2504_CR11","first-page":"77","volume":"315","author":"AW Hauswirth","year":"2006","unstructured":"Hauswirth AW, Florian S, Schernthaner GH, Krauth MT, Sonneck K, Sperr WR, et al. Expression of cell surface antigens on mast cells: mast cell phenotyping. Methods Mol Biol. 2006;315:77\u201390.","journal-title":"Methods Mol Biol"},{"key":"2504_CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/BC20110006","volume":"103","author":"L S\u00e1nchez-Mu\u00f1oz","year":"2011","unstructured":"S\u00e1nchez-Mu\u00f1oz L, Teod\u00f3sio C, Morgado JM, Escribano L. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders. Cell Biol. 2011;103:333\u201359.","journal-title":"Cell Biol"},{"key":"2504_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.iac.2014.01.008","volume":"34","author":"L S\u00e1nchez-Mu\u00f1oz","year":"2014","unstructured":"S\u00e1nchez-Mu\u00f1oz L, Teodosio C, Morgado JM, Perbellini O, Mayado A, Alvarez-Twose I, et al. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool. Immunol Allergy Clin North Am. 2014;34:297\u2013313.","journal-title":"Immunol Allergy Clin North Am"},{"key":"2504_CR14","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","volume":"91","author":"L Escribano","year":"1998","unstructured":"Escribano L, Orfao A, D\u00edaz-Agustin B, Villarrubia J, Cerver\u00f3 C, L\u00f3pez A, et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood. 1998;91:2731\u20136.","journal-title":"Blood"},{"key":"2504_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","volume":"25","author":"L Escribano","year":"2001","unstructured":"Escribano L, D\u00edaz-Agust\u00edn B, Bellas C, Naval\u00f3n R, Nu\u00f1ez R, Sperr WR, et al. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res. 2001;25:563\u201370.","journal-title":"Leuk Res"},{"key":"2504_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1034\/j.1600-065X.2001.790108.x","volume":"179","author":"P Valent","year":"2001","unstructured":"Valent P, Schernthaner GH, Sperr WR, Fritsch G, Agis H, Willheim M, et al. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev. 2001;179:74\u201381.","journal-title":"Immunol Rev"},{"key":"2504_CR17","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1182\/blood.V98.13.3784","volume":"98","author":"GH Schernthaner","year":"2001","unstructured":"Schernthaner GH, Jordan JH, Ghannadan M, Agis H, Bevec D, Nu\u00f1ez R, et al. Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. Blood. 2001;98:3784\u201392.","journal-title":"Blood"},{"key":"2504_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.semcancer.2019.07.025","volume":"60","author":"P Valent","year":"2020","unstructured":"Valent P, Sadovnik I, Eisenwort G, Herrmann H, Bauer K, Mueller N, et al. Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms. Semin Cancer Biol. 2020;60:191\u2013201.","journal-title":"Semin Cancer Biol"},{"key":"2504_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/modpathol.2010.224","volume":"24","author":"K Sotlar","year":"2011","unstructured":"Sotlar K, Cerny-Reiterer S, Petat-Dutter K, Hessel H, Berezowska S, M\u00fcllauer L, et al. Aberrant epression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol. 2011;24:585\u201395.","journal-title":"Mod Pathol"},{"key":"2504_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3109\/10428194.2010.550072","volume":"52","author":"P Valent","year":"2011","unstructured":"Valent P, Sotlar K, Horny H-P. Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms. Leuk Lymphoma. 2011;52:740\u20134.","journal-title":"Leuk Lymphoma"},{"key":"2504_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/his.12221","volume":"63","author":"JM Morgado","year":"2013","unstructured":"Morgado JM, Perbellini O, Johnson RC, Teod\u00f3sio C, Matito A, \u00c1lvarez-Twose I, et al. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. Histopathology. 2013;63:780\u20137.","journal-title":"Histopathology"},{"key":"2504_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.iac.2014.01.006","volume":"34","author":"B Van Anrooij","year":"2014","unstructured":"Van Anrooij B, Kluin PM, Oude Elberink JNG, Kluin-Nelemans JC. CD30 in systemic mastocytosis. Immunol Allergy Clin North Am. 2014;34:341\u201355.","journal-title":"Immunol Allergy Clin North Am"},{"key":"2504_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","volume":"30","author":"L Escribano","year":"1997","unstructured":"Escribano L, Orfao A, Villarrubia J, Mart\u00edn F, Madruga JI, Cuevas M, et al. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry. 1997;30:98\u2013102.","journal-title":"Cytometry"},{"key":"2504_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaip.2018.09.024","volume":"7","author":"P Valent","year":"2019","unstructured":"Valent P, Oude Elberink JNG, Gorska A, Lange M, Zanotti R, van Anrooij B, et al. The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives. J Allergy Clin Immunol Pr. 2019;7:81\u201387.","journal-title":"J Allergy Clin Immunol Pr"},{"key":"2504_CR25","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.jaip.2023.02.021","volume":"11","author":"P Valent","year":"2023","unstructured":"Valent P, Hartmann K, Bonadonna P, Sperr WR, Niedoszytko M, Hermine O, et al. European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives. J Allergy Clin Immunol Pr. 2023;11:1706\u201317.","journal-title":"J Allergy Clin Immunol Pr"},{"key":"2504_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.beha.2010.07.003","volume":"23","author":"P Valent","year":"2010","unstructured":"Valent P, Cerny-Reiterer S, Herrmann H, Mirkina I, George TI, Sotlar K, et al. Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells. Best Pr Res Clin Haematol. 2010;23:369\u201378.","journal-title":"Best Pr Res Clin Haematol"},{"key":"2504_CR27","doi-asserted-by":"publisher","unstructured":"Rossignol J, Georgin-Lavialle S, Canioni D, Beganovic O, Brouzes C, Fain O, et al. Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis. Haematologica. 2024. 29. https:\/\/doi.org\/10.3324\/haematol.2024.285740.","DOI":"10.3324\/haematol.2024.285740"},{"key":"2504_CR28","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1200\/JCO.19.00640","volume":"37","author":"M Jawhar","year":"2019","unstructured":"Jawhar M, Schwaab J, \u00c1lvarez-Twose I, Shoumariyeh K, Naumann N, L\u00fcbke J, et al. MARS: mutation-adjusted risk score for advanced systemic mastocytosis. J Clin Oncol. 2019;37:2846\u201356.","journal-title":"J Clin Oncol"},{"key":"2504_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jaip.2022.10.051","volume":"11","author":"J L\u00fcbke","year":"2023","unstructured":"L\u00fcbke J, Schwaab J, Christen D, Elberink HO, Span B, Niedoszytko M, et al. Prognostic impact of organomegaly in mastocytosis: an analysis of the european competence network on mastocytosis. J Allergy Clin Immunol Pr. 2023;11:581\u2013590.e5.","journal-title":"J Allergy Clin Immunol Pr"},{"key":"2504_CR30","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1182\/blood-2015-03-637728","volume":"126","author":"K Blatt","year":"2015","unstructured":"Blatt K, Cemy-Reiterer S, Schwaab J, Sotlar K, Eisenwort G, Stefanzl G, et al. Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis. Blood. 2015;126:2832\u201341.","journal-title":"Blood"},{"key":"2504_CR31","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1158\/1078-0432.CCR-15-0767","volume":"22","author":"I Sadovnik","year":"2016","unstructured":"Sadovnik I, Hoelbl-Kovacic A, Herrmann H, Eisenwort G, Cerny-Reiterer S, Warsch W, et al. Identification of CD25 as STAT5-dependent growth regulator of leukemic stem cells in Ph+ CML. Clin Cancer Res. 2016;22:2051\u201361.","journal-title":"Clin Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02504-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02504-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02504-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T11:11:08Z","timestamp":1741086668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-024-02504-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2504"],"URL":"https:\/\/doi.org\/10.1038\/s41375-024-02504-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4773242\/v1","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"20 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Conflicts of interest declared by the co-autors: Axel R\u00fcfer: Advisory boards: Blueprint Medicines; Oliver Hermine: Research funding support from AB science and Novartis. Advisory board of AB science; Patrizia Bonadonna: Honoraria: Blueprint Medicines; Karin Hartmann: Lectures\/consultancy: ALK, Allergopharma, BioCryst, Blueprint Medicines, Cogent, KalVista, Leo, Menarini, Novartis, Pfizer, Sanofi, Takeda, Thermo Fisher; Vito Sabato: Advisory boards: Blueprint Medicines, Cogent, Novartis, Telios. Honoraria: Thermo Fisher; Knut Brockow: Advisory board and honoraria: Blueprint Medicines; Nikolas von Bubnoff: Honoraria Novartis, Takeda, Astra Zeneca, Janssen-Cilag; Paul van Daele: Lectures\/consultancy: Novartis, involved in clinical trials for Cogent Biosciences and Blueprint Medicines; Ingunn Dybedal: Advisory board and honoraria: Blueprint Medicines; Chiara Elena: Advisory board and honoraria: Blueprint Medicines, Gilead; Marc Heizmann: Advisory board and honoraria: Novartis; Jens Panse: Advisory board and honoraria: Blueprint Medicines, Novartis, Deciphera; Friederike Wortmann: Advisory board and honoraria: Blueprint Medicines, Novartis, Pierre Fabre, Abbvie; Jason Gotlib: Research Grant (funds for administration of clinical trials): Novartis, Blueprint Medicines, Deciphera, Cogent Biosciences; Advisory Board and Honoraria: Blueprint Medicines, Novartis, Deciphera, Cogent Biosciences; Reimbursement of travel expenses: Novartis, Blueprint Medicines; Andreas Reiter: Honoraria: Novartis, Blueprint Medicines, Incyte, Celgene\/Bristol Myers Squibb, AOP Orphan Pharmaceuticals, GlaxoSmithKline, AbbVie; Consulting or Advisory Role: Novartis, Blueprint Medicines, Incyte, Celgene\/Bristol Myers Squibb, AOP Orphan Pharmaceuticals, AbbVie; Massimo Triggiani: Advisory Board and Honoraria: Blueprint Medicines, Novartis; Wolfgang R. Sperr: Honoraria from AbbVie, Astellas, Blueprint, BMS-Celgene, Daiichi Sankyo, Deciphera, Incyte, Jazz Pharmaceuticals, Laboratoires Delbert, Novartis, Otsuka, Pfizer, Servier, Stemline, Thermo Fisher; Peter Valent: 1. Advisory board - honoraria: AOP Orphan, Blueprint, Cogent, Delbert, Incyte, Novartis, PentaBase, Pfizer, Stemline. 2. Research grant: AOP Orphan, Pfizer. The remaining co-authors declared no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The ECNM registry study was approved by the responsible local ethics committee of each participating ECNM center. Written informed consent was obtained from all patients included in the ECNM registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}